Enzyme Kinetics

Drug Metabolism in Drug Design and Development: Basic Concepts and Practice

Volumn , Issue , 2007, Pages 89-112

  Tracy, Timothy S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

in vitro drug metabolism kinetic profile; New chemical entity metabolism enzyme kinetic parameters; Substrate enzyme interactions

Indexed keywords

EID: 79955479479     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470191699.ch4     Document Type: Chapter

References (22)

1. Cornish-Bowden A. A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors. Biochemistry J 1974; 137:143-144.
2. Cornish-Bowden A. Fundamentals of Enzyme Kinetics. London: Portland Press; 2004.
3. Dabrowski MJ, Schrag ML, Wienkers LC, Atkins WM. Pyrene.pyrene complexes at the active site of cytochrome P450 3A4: evidence for a multiple substrate binding site. J Am Chem Soc 2002;124:11866-11867.
4. Dixon M. The determination of enzyme inhibitor constants. Biochemistry 1953;55:170-171.
5. Dowd JE, Riggs DS. A comparison of estimates of Michaelis-Menten kinetic constants from various linear transformations. J Biol Chem 1965;240:863-869.
6. Egnell AC, Houston JB, Boyer CS. In vivo CYP3A4 heteroactivation is a possible mechanism for the drug interaction between felbamate and carbamazepine. J Pharmacol Exp Ther 2003;305:1251-1262.
7. Houston JB. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem Pharmacol 1994;47:1469-1479.
8. Hummel MA, Gannett PM, Aguilar JS, Tracy TS. Effector-mediated alteration of substrate orientation in cytochrome P450 2C9. Biochemistry 2004;43:7207-7214.
9. Hutzler JM, Hauer MJ, Tracy TS. Dapsone activation of CYP2C9-mediated metabolism: evidence for activation of multiple substrates and a two-site model. Drug Metab Dispos 2001;29:1029-1034.
10. Hutzler JM, Tracy TS. Atypical kinetic profiles in drug metabolism reactions. Drug Metab Dispos 2002;30:355-362.
11. Hutzler JM, Wienkers LC, Wahlstrom JL, Carlson TJ, Tracy TS. Activation of cytochrome P450 2C9-mediated metabolism: mechanistic evidence in support of kinetic observations. Arch Biochem Biophys 2003;410:16-24.
12. Kenworthy KE, Clarke SE, Andrews J, Houston JB. Multisite kinetic models for CYP3 A4:simultaneous activation and inhibition of diazepam and testosterone metabolism. Drug Metab Dispos 2001;29:1644-1651.
13. Korzekwa KR, Krishnamachary N, Shou M, Ogai A, Parise RA, Rettie AE, Gonzalez FJ, Tracy TS. Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites. Biochemistry 1998;37:4137-4147.
14. Lin Y, Lu P, Tang C, Mei Q, Sandig G, Rodrigues AD, Rushmore TH, Shou M. Substrate inhibition kinetics for cytochrome P450-catalyzed reactions. Drug Metab Dispos 2001;29:368-374.
15. Pfeiffer E, Treiling CR, Hoehle SI, Metzler M. Isoflavones modulate the glucuronidation of estradiol in human liver microsomes. Carcinogenesis 2005;26:2172-2178.
16. Rock DA, Perkins BN, Wahlstrom J, Jones JP. A method for determining two substrates binding in the same active site of cytochrome P450B M3: an explanation of high energy omega product formation. Arch Biochem Biophys 2003;416:9-16.
17. Segel IH. Rapid Equilibrium Bireactant and Terreactant Systems. New York: John Wiley & Sons, Inc.; 1975.
18. Shou M, Grogan J, Mancewicz JA, Krausz KW, Gonzalez FJ, Gelboin HV, Korzekwa KR. Activation of CYP3A4: Evidence for the simultaneous binding of two substrates in a cytochrome P450 active site. Biochemistry 1994;33:6450-6455.
19. Shou M, Mei Q, Ettore MW, Jr, Dai R, Baillie TA, Rushmore TH. Sigmoidal kinetic model for two co-operative substrate-binding sites in a cytochrome P450 3A4 active site: an example of the metabolism of diazepam and its derivatives. Biochem J 1999; 340 (Pt 3):845-853.
20. Silverman RB. Mechanism-Based Enzyme Inactivation: Chemistry and Enzymology. Boca Raton: CRC Press; 1998.
21. Taub ME, Podila L, Ely D, Almeida I. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity. Drug Metab Dispos 2005;33:1679-1687.
22. Witherow LE, Houston JB. Sigmoidal kinetics of CYP3A substrates: an approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat. J Pharmacol Exp Ther 1999;290:58-65.